Pub Date : 2026-03-05DOI: 10.1186/s13643-026-03124-x
Matthias Pillny, Jason Holden, Dan Devoe, Peter Link, Eric Granholm
Background: Cognitive Behavioral Social Skills Training (CBSST) is a targeted psychological intervention designed to improve daily functioning and to address negative symptoms in individuals diagnosed with schizophrenia. Despite evidence from clinical trials suggesting beneficial effects of CBSST on functioning and negative symptoms, the overall efficacy of CBSST remains to be quantified. Furthermore, potential moderators and mediators of treatment outcomes remain elusive. This protocol outlines an individual participant data meta-analysis (IPD-MA) with the objective to examine the efficacy of CBSST on psychosocial functioning in schizophrenia.
Method: In accordance with the Preferred Reporting Items for a Systematic review and Meta-Analysis of Individual Participant Data (PRISMA-IPD) guidelines, we will conduct a systematic literature search and employ two-stage and one-stage meta-analytical approaches. The meta-analytical models will evaluate the overall effect of CBSST relative to control treatments in randomized-control trials, identify participant-level (e.g., age, cognitive impairment) and study-level (e.g., individual vs. group settings) predictors of change, and explore the mechanisms that mediate improvement in functioning, such as skills acquisition and cognitive restructuring of defeatist attitudes. Furthermore, the analysis will attempt to determine the optimal amount of CBSST sessions required to enhance functioning and evaluate the impact of patient-level factors driving delivered dosage.
Discussion: The objective of this study is to contribute to the existing literature by addressing the current gaps in understanding the efficacy of CBSST and identifying critical factors for treatment success. Our findings will have the potential to inform personalized treatment planning and the development of clinical guideline recommendations focusing on functional outcomes and negative symptoms in people with schizophrenia.
{"title":"Effect of cognitive behavioral social skills training on functioning in schizophrenia: protocol for an individual participant data meta-analysis of randomized-control trials.","authors":"Matthias Pillny, Jason Holden, Dan Devoe, Peter Link, Eric Granholm","doi":"10.1186/s13643-026-03124-x","DOIUrl":"10.1186/s13643-026-03124-x","url":null,"abstract":"<p><strong>Background: </strong>Cognitive Behavioral Social Skills Training (CBSST) is a targeted psychological intervention designed to improve daily functioning and to address negative symptoms in individuals diagnosed with schizophrenia. Despite evidence from clinical trials suggesting beneficial effects of CBSST on functioning and negative symptoms, the overall efficacy of CBSST remains to be quantified. Furthermore, potential moderators and mediators of treatment outcomes remain elusive. This protocol outlines an individual participant data meta-analysis (IPD-MA) with the objective to examine the efficacy of CBSST on psychosocial functioning in schizophrenia.</p><p><strong>Method: </strong>In accordance with the Preferred Reporting Items for a Systematic review and Meta-Analysis of Individual Participant Data (PRISMA-IPD) guidelines, we will conduct a systematic literature search and employ two-stage and one-stage meta-analytical approaches. The meta-analytical models will evaluate the overall effect of CBSST relative to control treatments in randomized-control trials, identify participant-level (e.g., age, cognitive impairment) and study-level (e.g., individual vs. group settings) predictors of change, and explore the mechanisms that mediate improvement in functioning, such as skills acquisition and cognitive restructuring of defeatist attitudes. Furthermore, the analysis will attempt to determine the optimal amount of CBSST sessions required to enhance functioning and evaluate the impact of patient-level factors driving delivered dosage.</p><p><strong>Discussion: </strong>The objective of this study is to contribute to the existing literature by addressing the current gaps in understanding the efficacy of CBSST and identifying critical factors for treatment success. Our findings will have the potential to inform personalized treatment planning and the development of clinical guideline recommendations focusing on functional outcomes and negative symptoms in people with schizophrenia.</p><p><strong>Systematic review registration: </strong>PROSPERO CRD42024605353.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13003740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147355073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-05DOI: 10.1186/s13643-026-03144-7
Luca Murazzano, Paolo Landa, Frédéric Bergeron, André Côté, Jean-Baptiste Gartner, Mohamed Hakim Raki
Background: Process mining is increasingly utilized in healthcare to analyze and optimize clinical pathways, offering opportunities to enhance care efficiency and patient outcomes. This systematic review aims to synthesize evidence on the application of process mining to clinical pathways, focusing on its impact on patient outcomes, operational efficiency, and pathway structure.
Methods: A systematic search will be conducted in MEDLINE, Embase, Google Scholar, Web of Science, and ABI/Inform for studies published from 1999 onward. Eligible studies include observational studies, case reports, conference papers, and meta-analyses focusing on process mining applications to clinical pathways in hospital settings. Two independent reviewers will screen studies, extract data, and assess quality using the Mixed Methods Appraisal Tool (MMAT). Data will be extracted considering several pieces of information such as clinical pathway, settings, health outcomes, costs, and indicators, and will be presented in a structured format. A narrative synthesis will be conducted, and findings will be categorized and thematically analysed where possible. Disagreements will be resolved through consensus. Primary outcomes include improvements in care efficiency, patient flow, compliance with clinical guidelines, and reduction in delays or resource use. Secondary outcomes include challenges and limitations in applying process mining techniques.
Discussion: This review will provide a comprehensive synthesis of process mining applications in clinical pathways, highlighting successful strategies, key challenges, and future opportunities. Findings will inform healthcare professionals, policymakers, and researchers on leveraging process mining to optimize clinical care.
背景:流程挖掘越来越多地用于医疗保健分析和优化临床途径,为提高护理效率和患者预后提供了机会。本系统综述旨在综合流程挖掘在临床路径中的应用证据,重点关注其对患者预后、操作效率和路径结构的影响。方法:系统检索MEDLINE、Embase、b谷歌Scholar、Web of Science、ABI/Inform等网站1999年以来发表的相关研究。符合条件的研究包括观察性研究、病例报告、会议论文和关注流程挖掘在医院临床路径应用的荟萃分析。两名独立审稿人将筛选研究,提取数据,并使用混合方法评估工具(MMAT)评估质量。数据的提取将考虑诸如临床途径、环境、健康结果、成本和指标等若干信息,并将以结构化格式呈现。将进行叙述综合,并尽可能对调查结果进行分类和专题分析。分歧将通过协商一致来解决。主要结果包括护理效率的提高、患者流量、临床指南的遵守以及延误或资源使用的减少。次要结果包括应用过程挖掘技术的挑战和限制。讨论:本综述将提供过程挖掘在临床途径中的应用的综合,突出成功的策略,关键挑战和未来的机会。研究结果将为医疗保健专业人员、政策制定者和研究人员提供利用流程挖掘优化临床护理的信息。系统评价注册号:PROSPERO CRD42024584540。
{"title":"The application of process mining for clinical pathways: a systematic literature review protocol.","authors":"Luca Murazzano, Paolo Landa, Frédéric Bergeron, André Côté, Jean-Baptiste Gartner, Mohamed Hakim Raki","doi":"10.1186/s13643-026-03144-7","DOIUrl":"https://doi.org/10.1186/s13643-026-03144-7","url":null,"abstract":"<p><strong>Background: </strong>Process mining is increasingly utilized in healthcare to analyze and optimize clinical pathways, offering opportunities to enhance care efficiency and patient outcomes. This systematic review aims to synthesize evidence on the application of process mining to clinical pathways, focusing on its impact on patient outcomes, operational efficiency, and pathway structure.</p><p><strong>Methods: </strong>A systematic search will be conducted in MEDLINE, Embase, Google Scholar, Web of Science, and ABI/Inform for studies published from 1999 onward. Eligible studies include observational studies, case reports, conference papers, and meta-analyses focusing on process mining applications to clinical pathways in hospital settings. Two independent reviewers will screen studies, extract data, and assess quality using the Mixed Methods Appraisal Tool (MMAT). Data will be extracted considering several pieces of information such as clinical pathway, settings, health outcomes, costs, and indicators, and will be presented in a structured format. A narrative synthesis will be conducted, and findings will be categorized and thematically analysed where possible. Disagreements will be resolved through consensus. Primary outcomes include improvements in care efficiency, patient flow, compliance with clinical guidelines, and reduction in delays or resource use. Secondary outcomes include challenges and limitations in applying process mining techniques.</p><p><strong>Discussion: </strong>This review will provide a comprehensive synthesis of process mining applications in clinical pathways, highlighting successful strategies, key challenges, and future opportunities. Findings will inform healthcare professionals, policymakers, and researchers on leveraging process mining to optimize clinical care.</p><p><strong>Systematic review registration: </strong>PROSPERO CRD42024584540.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147356127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-04DOI: 10.1186/s13643-026-03108-x
Lavra Nanayakkara, Anna Rangan, Gopala Rangan
Background: Chronic diseases (cardiovascular, cancer, respiratory, diabetes and chronic kidney disease) account for over 80% of global mortality and remain a leading public health challenge. Although water intake is essential to physiological function and homeostasis, its role in the long-term prevention of chronic diseases remains underexplored. Current guidelines are vague, inconsistent, and aimed at preventing acute dehydration, without robust evidence supporting benefits for chronic disease prevention. This study outlines a preliminary systematic review designed to synthesise existing literature on plain water intake and chronic disease risk, with the aim of laying the groundwork for future public health recommendations.
Methods: This review will include English-language randomised controlled trials, cross-sectional studies, case-control studies, and cohort studies assessing the relationship between plain water intake and the incidence of chronic diseases in healthy adults. Only studies measuring oral plain water consumption will be included. Adequate water intake is defined as 2 to 3.7 l daily, based on current international and national recommendations. Eligible studies must report on the risk of developing one or more major chronic diseases and provide quantifiable outcomes (e.g. odds ratios, or relative risks with 95% confidence intervals). A meta-analysis will be conducted where appropriate, and subgroup and sensitivity analyses will explore potential sources of heterogeneity.
Discussion: This systematic review is the first to collate evidence on the collective relationship between plain water intake and multiple chronic disease outcomes. By adopting a binary classification (adequate versus inadequate intake), this preliminary synthesis aims to generate practical and actionable insights that are accessible to the general public. Recognising the fragmented nature of existing research, the findings will serve as a foundation for future studies to refine thresholds and inform clinical and public health guidelines. Limitations such as self-reported data, residual confounding, exclusion of non-English studies, and variability in intake measurement, will be transparently addressed in the interpretations of results.
Systematic review registration: PROSPERO; CRD420251021321. It can be accessed from https://www.crd.york.ac.uk/PROSPERO/view/CRD420251021321.
{"title":"Effect of adequate daily water intake versus inadequate water intake on the risk of major chronic diseases in healthy adults: a systematic review protocol.","authors":"Lavra Nanayakkara, Anna Rangan, Gopala Rangan","doi":"10.1186/s13643-026-03108-x","DOIUrl":"https://doi.org/10.1186/s13643-026-03108-x","url":null,"abstract":"<p><strong>Background: </strong>Chronic diseases (cardiovascular, cancer, respiratory, diabetes and chronic kidney disease) account for over 80% of global mortality and remain a leading public health challenge. Although water intake is essential to physiological function and homeostasis, its role in the long-term prevention of chronic diseases remains underexplored. Current guidelines are vague, inconsistent, and aimed at preventing acute dehydration, without robust evidence supporting benefits for chronic disease prevention. This study outlines a preliminary systematic review designed to synthesise existing literature on plain water intake and chronic disease risk, with the aim of laying the groundwork for future public health recommendations.</p><p><strong>Methods: </strong>This review will include English-language randomised controlled trials, cross-sectional studies, case-control studies, and cohort studies assessing the relationship between plain water intake and the incidence of chronic diseases in healthy adults. Only studies measuring oral plain water consumption will be included. Adequate water intake is defined as 2 to 3.7 l daily, based on current international and national recommendations. Eligible studies must report on the risk of developing one or more major chronic diseases and provide quantifiable outcomes (e.g. odds ratios, or relative risks with 95% confidence intervals). A meta-analysis will be conducted where appropriate, and subgroup and sensitivity analyses will explore potential sources of heterogeneity.</p><p><strong>Discussion: </strong>This systematic review is the first to collate evidence on the collective relationship between plain water intake and multiple chronic disease outcomes. By adopting a binary classification (adequate versus inadequate intake), this preliminary synthesis aims to generate practical and actionable insights that are accessible to the general public. Recognising the fragmented nature of existing research, the findings will serve as a foundation for future studies to refine thresholds and inform clinical and public health guidelines. Limitations such as self-reported data, residual confounding, exclusion of non-English studies, and variability in intake measurement, will be transparently addressed in the interpretations of results.</p><p><strong>Systematic review registration: </strong>PROSPERO; CRD420251021321. It can be accessed from https://www.crd.york.ac.uk/PROSPERO/view/CRD420251021321.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147349343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-04DOI: 10.1186/s13643-026-03135-8
Ferdinand C Mukumbang, Gabriela Uribe, John G Eastwood, Ilan Katz, Carmen Huckel Schneider
Background: Place-based initiatives (PBIs) are increasingly being used to address complex and multi-faceted issues that cannot be resolved using conventional policy and service delivery approaches. PBIs are interventions designed and delivered to address the unique circumstances of a place that cannot be resolved using conventional, one-size-fits-all policy approaches. Based on the premise that health and social needs coexist within a community, PBIs adopt people-centred and integrated health and social care approaches. With the emergence of hybrid in-person and remote service delivery approaches, there is an increasing policy mandate to incorporate hybrid service delivery in PBIs. The WHO's integrated and people-centred approach to delivering complex inter-related health and social issues encourages the adoption of these approaches during the implementation of PBI. Nevertheless, there is a limited appreciation of whether and how these approaches are integrated. This research, therefore, takes a novel approach by exploring the implementation of people-centred, integrated, hybrid service delivery approaches in PBIs. The review protocol outlines a plan for exploring community-led, integrated health and social, and hybrid in-person and face-to-face service delivery models in PBIs.
Methods: The proposed scoping review will follow the Joanna Briggs Institute approach for conducting scoping reviews and report it according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping review-PRISMA-ScR. A search of electronic databases (MEDLINE, EMBASE, the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, Social Work Abstracts, Social Services Abstracts, AJOL, and African Medicus Index). Articles will be included if they discuss PBIs that have two or all three service delivery approaches: (1) community-led, (2) health and social care integrated approach, and (3) hybrid in-person and remote service delivery. The READ (readying material, extracting data, analyzing data, and distilling findings) approach will be used to analyse the selected data sources. A framework thematic approach will be applied to identify the adoption of the relevant approaches to implementing PBIs.
Significance: We anticipate this review will help researchers, programme designers, and implementers understand how existing tools better address health equity considerations in intersectoral partnerships and pave the way for developing new, comprehensive tools suitable for designing PBIs.
{"title":"Implementation of people-centred, integrated, and hybrid service delivery approaches in place-based initiatives: a scoping review protocol.","authors":"Ferdinand C Mukumbang, Gabriela Uribe, John G Eastwood, Ilan Katz, Carmen Huckel Schneider","doi":"10.1186/s13643-026-03135-8","DOIUrl":"https://doi.org/10.1186/s13643-026-03135-8","url":null,"abstract":"<p><strong>Background: </strong>Place-based initiatives (PBIs) are increasingly being used to address complex and multi-faceted issues that cannot be resolved using conventional policy and service delivery approaches. PBIs are interventions designed and delivered to address the unique circumstances of a place that cannot be resolved using conventional, one-size-fits-all policy approaches. Based on the premise that health and social needs coexist within a community, PBIs adopt people-centred and integrated health and social care approaches. With the emergence of hybrid in-person and remote service delivery approaches, there is an increasing policy mandate to incorporate hybrid service delivery in PBIs. The WHO's integrated and people-centred approach to delivering complex inter-related health and social issues encourages the adoption of these approaches during the implementation of PBI. Nevertheless, there is a limited appreciation of whether and how these approaches are integrated. This research, therefore, takes a novel approach by exploring the implementation of people-centred, integrated, hybrid service delivery approaches in PBIs. The review protocol outlines a plan for exploring community-led, integrated health and social, and hybrid in-person and face-to-face service delivery models in PBIs.</p><p><strong>Methods: </strong>The proposed scoping review will follow the Joanna Briggs Institute approach for conducting scoping reviews and report it according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping review-PRISMA-ScR. A search of electronic databases (MEDLINE, EMBASE, the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, Social Work Abstracts, Social Services Abstracts, AJOL, and African Medicus Index). Articles will be included if they discuss PBIs that have two or all three service delivery approaches: (1) community-led, (2) health and social care integrated approach, and (3) hybrid in-person and remote service delivery. The READ (readying material, extracting data, analyzing data, and distilling findings) approach will be used to analyse the selected data sources. A framework thematic approach will be applied to identify the adoption of the relevant approaches to implementing PBIs.</p><p><strong>Significance: </strong>We anticipate this review will help researchers, programme designers, and implementers understand how existing tools better address health equity considerations in intersectoral partnerships and pave the way for developing new, comprehensive tools suitable for designing PBIs.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147349380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-03DOI: 10.1186/s13643-026-03129-6
Yousef Tanas, Grace Gasper, Sarya Swed, Aldona J SwedSpiegel
Background: In ptotic/macromastic breasts, nipple-sparing mastectomy (NSM) risks ischemic complications. Staging with nipple repositioning (mastopexy or breast reduction) may improve perfusion, but uncertainty remains regarding safety and optimal timing.
Methods: PRISMA guidelines will be followed. The database search will be conducted using MEDLINE (PubMed), Scopus, Web of Science, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and ClinicalTrials.org targeting studies from inception to search date. Meta-analysis will be performed using Review Manager 5.4 software; forest plots will be used for two-arm studies to calculate pooled risk ratios, heterogeneity using I2 statistics, and p-value for overall effect.
Discussion: Due to the conflicting studies regarding the optimal timing and safety of nipple-repositioning before NSM, a systematic review and meta-analysis is required to provide more definitive evidence-based recommendations regarding the optimal timing and safety of this staged approach. Limitations may include the predominance of observational studies, heterogeneity in intervals, and inconsistent reporting that may limit the certainty of our conclusions.
背景:在上睑下垂/巨大乳房中,保留乳头的乳房切除术(NSM)有缺血性并发症的风险。乳头复位(乳房切除术或乳房缩小)的分期可以改善灌注,但安全性和最佳时机仍不确定。方法:遵循PRISMA指南。数据库检索将使用MEDLINE (PubMed)、Scopus、Web of Science、Cochrane Central Register of Controlled Trials、Cochrane database of Systematic Reviews和ClinicalTrials.org从开始到检索日期针对研究进行检索。meta分析采用Review Manager 5.4软件;森林样地将用于两组研究,以计算合并风险比、I2统计的异质性和总体效果的p值。讨论:由于关于NSM前乳头复位的最佳时机和安全性的研究相互矛盾,需要进行系统回顾和荟萃分析,以提供更明确的循证建议,关于这种分阶段方法的最佳时机和安全性。局限性可能包括观察性研究的优势,间隔的异质性,以及可能限制我们结论确定性的不一致的报告。系统评价注册:ROSPERO CRD42024513738。
{"title":"Safety and optimal timing of staged nipple-sparing mastectomy following nipple repositioning in ptotic breasts: a systematic review protocol.","authors":"Yousef Tanas, Grace Gasper, Sarya Swed, Aldona J SwedSpiegel","doi":"10.1186/s13643-026-03129-6","DOIUrl":"https://doi.org/10.1186/s13643-026-03129-6","url":null,"abstract":"<p><strong>Background: </strong>In ptotic/macromastic breasts, nipple-sparing mastectomy (NSM) risks ischemic complications. Staging with nipple repositioning (mastopexy or breast reduction) may improve perfusion, but uncertainty remains regarding safety and optimal timing.</p><p><strong>Methods: </strong>PRISMA guidelines will be followed. The database search will be conducted using MEDLINE (PubMed), Scopus, Web of Science, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and ClinicalTrials.org targeting studies from inception to search date. Meta-analysis will be performed using Review Manager 5.4 software; forest plots will be used for two-arm studies to calculate pooled risk ratios, heterogeneity using I<sup>2</sup> statistics, and p-value for overall effect.</p><p><strong>Discussion: </strong>Due to the conflicting studies regarding the optimal timing and safety of nipple-repositioning before NSM, a systematic review and meta-analysis is required to provide more definitive evidence-based recommendations regarding the optimal timing and safety of this staged approach. Limitations may include the predominance of observational studies, heterogeneity in intervals, and inconsistent reporting that may limit the certainty of our conclusions.</p><p><strong>Systematic review registration: </strong>ROSPERO CRD42024513738.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147349326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-03DOI: 10.1186/s13643-026-03139-4
Wei You, Kejimu Sunzi, Quanmin Deng, Lina Yin, Yang Gao, Yao Chen, Cheng Lei
Background: Cerebral palsy (CP) is the leading cause of childhood motor disability, often requiring intensive, long-term rehabilitation to improve motor function and independence in daily activities. Robot-assisted therapy has emerged as a promising intervention, as it can deliver high-intensity, task-specific, and motivating treatment. However, evidence for its superiority over conventional rehabilitation interventions (CRIs) is inconsistent, and a comprehensive quantitative synthesis is lacking. This protocol details a systematic review and meta-analysis to evaluate the effectiveness of robot-assisted therapy on motor outcomes in children with CP.
Methods: This protocol has been developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement. We will conduct a comprehensive search of five electronic databases (PubMed, Embase, Web of Science, CINAHL, and the Cochrane Library) from their inception to June 2025. The review will include randomized controlled trials (RCTs) comparing robot-assisted therapy with CRIs in children with CP. Two independent reviewers will screen titles, abstracts, and full texts and extract relevant data. Primary outcomes will include measures of gross motor function, activities of daily living (ADL), gait, and balance. Secondary outcomes will include upper limb function and quality of life. Where appropriate, we will perform a meta-analysis using a random-effects model in Stata 14.0. We will investigate sources of heterogeneity using subgroup and sensitivity analyses. Publication bias will be assessed with funnel plots and Egger's test. Furthermore, Trial Sequential Analysis will be employed to assess the robustness of the findings and control for risks of random error. The overall quality of evidence will be evaluated using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) framework.
背景:脑瘫(CP)是儿童运动障碍的主要原因,通常需要密集、长期的康复来改善运动功能和日常活动的独立性。机器人辅助治疗已经成为一种很有前途的干预手段,因为它可以提供高强度、特定任务和激励治疗。然而,其优于传统康复干预(CRIs)的证据并不一致,而且缺乏全面的定量综合。本方案详细介绍了一项系统综述和荟萃分析,以评估机器人辅助治疗对cp儿童运动预后的有效性。方法:本方案是根据系统综述和荟萃分析方案的首选报告项目(PRISMA-P)声明制定的。我们将对5个电子数据库(PubMed、Embase、Web of Science、CINAHL和Cochrane Library)从建立到2025年6月进行全面检索。该综述将包括比较机器人辅助治疗与CRIs治疗CP患儿的随机对照试验(rct)。两名独立审稿人将筛选标题、摘要和全文并提取相关数据。主要结果包括大运动功能、日常生活活动(ADL)、步态和平衡。次要结果包括上肢功能和生活质量。在适当的情况下,我们将在Stata 14.0中使用随机效应模型进行meta分析。我们将使用亚组分析和敏感性分析来调查异质性的来源。发表偏倚将采用漏斗图和Egger检验进行评估。此外,将采用试验序列分析来评估研究结果的稳健性和对随机误差风险的控制。将使用建议、评估、发展和评估分级(GRADE)框架对证据的整体质量进行评估。系统评价注册:PROSPERO CRD420250652267。
{"title":"Effectiveness of robotic rehabilitation interventions in children with cerebral palsy: protocol for a systematic review and meta-analysis of randomized controlled trials.","authors":"Wei You, Kejimu Sunzi, Quanmin Deng, Lina Yin, Yang Gao, Yao Chen, Cheng Lei","doi":"10.1186/s13643-026-03139-4","DOIUrl":"https://doi.org/10.1186/s13643-026-03139-4","url":null,"abstract":"<p><strong>Background: </strong>Cerebral palsy (CP) is the leading cause of childhood motor disability, often requiring intensive, long-term rehabilitation to improve motor function and independence in daily activities. Robot-assisted therapy has emerged as a promising intervention, as it can deliver high-intensity, task-specific, and motivating treatment. However, evidence for its superiority over conventional rehabilitation interventions (CRIs) is inconsistent, and a comprehensive quantitative synthesis is lacking. This protocol details a systematic review and meta-analysis to evaluate the effectiveness of robot-assisted therapy on motor outcomes in children with CP.</p><p><strong>Methods: </strong>This protocol has been developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement. We will conduct a comprehensive search of five electronic databases (PubMed, Embase, Web of Science, CINAHL, and the Cochrane Library) from their inception to June 2025. The review will include randomized controlled trials (RCTs) comparing robot-assisted therapy with CRIs in children with CP. Two independent reviewers will screen titles, abstracts, and full texts and extract relevant data. Primary outcomes will include measures of gross motor function, activities of daily living (ADL), gait, and balance. Secondary outcomes will include upper limb function and quality of life. Where appropriate, we will perform a meta-analysis using a random-effects model in Stata 14.0. We will investigate sources of heterogeneity using subgroup and sensitivity analyses. Publication bias will be assessed with funnel plots and Egger's test. Furthermore, Trial Sequential Analysis will be employed to assess the robustness of the findings and control for risks of random error. The overall quality of evidence will be evaluated using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) framework.</p><p><strong>Systematic review registration: </strong>PROSPERO CRD420250652267.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147345276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-03DOI: 10.1186/s13643-026-03128-7
Jermaine M Dambi, Beatrice K Shava, Thandiwe Mashunye, Lloyd Dzapasi, Mutsa Mazarura, Dixon Chibanda
Background: The number of positive psychological interventions, including hope interventions to foster well-being and decrease the huge burden of mental conditions, has exponentially increased. Consequently, the number of hope outcome measures has also increased. The Hope Index (HI) is an extensively used hope outcome measure, but the evidence of its psychometric performance is fragmented. This systematic review and meta-analysis aims to critically appraise the psychometric properties of the Hope Index and assess its utility.
Methods/design: Two independent and blinded reviewers will search articles in PubMed, Scopus, Web of Science, CINAHL, PsychINFO, ProQuest Dissertations, and Google Scholar. Thereafter, three independent reviewers will then screen the retrieved articles. The risk of bias across studies will then be evaluated using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. The quality of the psychometric properties will be rated using a pre-set criterion and, after that, synthesized using the modified Grading of Recommendations Assessment, Development, and Evaluation (GRADE) checklist.
Discussion: The proposed systematic review will appraise the collective evidence of the psychometric robustness of the HI. The review will also assist in identifying psychometrics that may require further evaluation and make recommendations on the feasibility and utility of the HI.
背景:积极心理干预的数量呈指数增长,包括希望干预,以促进福祉和减少精神状况的巨大负担。因此,希望结果措施的数量也有所增加。希望指数(HI)是一种广泛使用的希望结果测量,但其心理测量性能的证据是碎片化的。本系统回顾和荟萃分析旨在批判性地评估希望指数的心理测量特性并评估其效用。方法/设计:两名独立的盲法审稿人将在PubMed、Scopus、Web of Science、CINAHL、PsychINFO、ProQuest Dissertations和谷歌Scholar中检索文章。之后,三名独立审稿人将对检索到的文章进行筛选。然后将使用基于共识的健康测量工具选择标准(COSMIN)核对表评估各研究的偏倚风险。心理测量属性的质量将使用预先设定的标准进行评级,然后使用修改后的建议评估、发展和评估分级(GRADE)检查表进行综合。讨论:提出的系统评价将评估HI的心理测量稳健性的集体证据。审查还将有助于确定可能需要进一步评估的心理测量学,并就HI的可行性和实用性提出建议。系统评价注册号:PROSPERO CRD42024511130。
{"title":"An evaluation of psychometric properties and utility of the Hope Index (HI): a systematic review and meta-analysis protocol.","authors":"Jermaine M Dambi, Beatrice K Shava, Thandiwe Mashunye, Lloyd Dzapasi, Mutsa Mazarura, Dixon Chibanda","doi":"10.1186/s13643-026-03128-7","DOIUrl":"https://doi.org/10.1186/s13643-026-03128-7","url":null,"abstract":"<p><strong>Background: </strong>The number of positive psychological interventions, including hope interventions to foster well-being and decrease the huge burden of mental conditions, has exponentially increased. Consequently, the number of hope outcome measures has also increased. The Hope Index (HI) is an extensively used hope outcome measure, but the evidence of its psychometric performance is fragmented. This systematic review and meta-analysis aims to critically appraise the psychometric properties of the Hope Index and assess its utility.</p><p><strong>Methods/design: </strong>Two independent and blinded reviewers will search articles in PubMed, Scopus, Web of Science, CINAHL, PsychINFO, ProQuest Dissertations, and Google Scholar. Thereafter, three independent reviewers will then screen the retrieved articles. The risk of bias across studies will then be evaluated using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. The quality of the psychometric properties will be rated using a pre-set criterion and, after that, synthesized using the modified Grading of Recommendations Assessment, Development, and Evaluation (GRADE) checklist.</p><p><strong>Discussion: </strong>The proposed systematic review will appraise the collective evidence of the psychometric robustness of the HI. The review will also assist in identifying psychometrics that may require further evaluation and make recommendations on the feasibility and utility of the HI.</p><p><strong>Systematic review registration: </strong>PROSPERO CRD42024511130.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147345217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-02DOI: 10.1186/s13643-026-03105-0
Cheng Fan, Qiaojun Zhang, Xiaohui Lei, Ben Ma, Boyi Li, Jiamin Yang, Yaofeng Li, Kai Wan, Lei Lu, Siduo Zhang, Bingtao Hu, Jing Yang, Weiqi Li, Peijia Fu, Hongfei Qiao
Background: Chronic low back pain (CLBP) is among the most disabling musculoskeletal disorders worldwide. Traditional in-person rehabilitation is often limited by time, geographic, and financial barriers. Telerehabilitation, which delivers personalized interventions through digital technologies (e.g., mobile apps, video coaching, wearable devices, virtual reality, and artificial intelligence feedback systems), is emerging as a complementary and alternative approach to conventional rehabilitation. However, there is currently no consensus on its efficacy and safety. Therefore, this study aims to evaluate the effectiveness of various forms of telerehabilitation in improving pain intensity, physical function, psychological symptoms, and quality of life in patients with CLBP. In addition, the study will assess intervention adherence, patient satisfaction, and safety (as measured by the incidence of adverse events) through systematic review and network meta-analysis.
Methods: A systematic search will be conducted in the following databases: PubMed/MEDLINE, EMBASE, Cochrane Library, Scopus, and Web of Science, covering all records from database inception to 31 December 2025. Eligible studies will include randomized controlled trials (RCTs) involving adults (≥ 18 years) with CLBP, comparing telerehabilitation interventions to any control intervention. The primary outcome will be pain intensity, while secondary outcomes will include physical function, psychological status, quality of life, and adverse events. The risk of bias for the included studies will be assessed using the revised Cochrane Risk of Bias 2.0 tool. The certainty of evidence will be evaluated using the CINeMA (Confidence in Network Meta-Analysis) web application. All network meta-analyses will be conducted within a frequentist framework using Stata 15 software and will apply random-effects models. Intervention rankings will be estimated using Surface Under the Cumulative Ranking (SUCRA) curves and illustrated with forest plots showing both individual and pooled effect sizes. Additional analyses will include assessments of statistical inconsistency, publication bias, heterogeneity, sensitivity, and subgroup differences.
Discussion: This study aimed to compare and rank the available evidence on various forms of telerehabilitation for the management of CLBP, as well as to assess its safety. The findings offer valuable insights for healthcare professionals and policymakers, supporting the advancement of patient-centered rehabilitation strategies.
背景:慢性腰痛(CLBP)是世界范围内最致残的肌肉骨骼疾病之一。传统的面对面康复常常受到时间、地理和经济障碍的限制。远程康复通过数字技术(如移动应用程序、视频指导、可穿戴设备、虚拟现实和人工智能反馈系统)提供个性化干预,正在成为传统康复的补充和替代方法。然而,目前对其有效性和安全性尚无共识。因此,本研究旨在评估各种形式的远程康复在改善CLBP患者疼痛强度、身体功能、心理症状和生活质量方面的有效性。此外,该研究将通过系统回顾和网络荟萃分析评估干预依从性、患者满意度和安全性(以不良事件发生率衡量)。方法:系统检索PubMed/MEDLINE、EMBASE、Cochrane Library、Scopus和Web of Science数据库,涵盖从数据库建立到2025年12月31日的所有记录。符合条件的研究将包括随机对照试验(RCTs),涉及成人(≥18岁)CLBP,比较远程康复干预与任何对照干预。主要结局是疼痛强度,次要结局包括身体功能、心理状态、生活质量和不良事件。纳入研究的偏倚风险将使用修订后的Cochrane风险偏倚2.0工具进行评估。证据的确定性将使用CINeMA(网络元分析的信心)网络应用程序进行评估。所有网络元分析将在使用Stata 15软件的频率分析框架内进行,并将应用随机效应模型。将使用累积排名曲线下的表面(SUCRA)来估计干预排名,并使用森林图来说明个体和综合效应大小。其他分析将包括统计不一致、发表偏倚、异质性、敏感性和亚组差异的评估。讨论:本研究旨在对各种形式的远程康复治疗CLBP的现有证据进行比较和排序,并评估其安全性。研究结果为医疗保健专业人员和政策制定者提供了有价值的见解,支持以患者为中心的康复策略的发展。系统评价注册:PROSPERO CRD420251015478。
{"title":"Telerehabilitation of chronic low back pain: protocol of a systematic review and network meta-analysis.","authors":"Cheng Fan, Qiaojun Zhang, Xiaohui Lei, Ben Ma, Boyi Li, Jiamin Yang, Yaofeng Li, Kai Wan, Lei Lu, Siduo Zhang, Bingtao Hu, Jing Yang, Weiqi Li, Peijia Fu, Hongfei Qiao","doi":"10.1186/s13643-026-03105-0","DOIUrl":"https://doi.org/10.1186/s13643-026-03105-0","url":null,"abstract":"<p><strong>Background: </strong>Chronic low back pain (CLBP) is among the most disabling musculoskeletal disorders worldwide. Traditional in-person rehabilitation is often limited by time, geographic, and financial barriers. Telerehabilitation, which delivers personalized interventions through digital technologies (e.g., mobile apps, video coaching, wearable devices, virtual reality, and artificial intelligence feedback systems), is emerging as a complementary and alternative approach to conventional rehabilitation. However, there is currently no consensus on its efficacy and safety. Therefore, this study aims to evaluate the effectiveness of various forms of telerehabilitation in improving pain intensity, physical function, psychological symptoms, and quality of life in patients with CLBP. In addition, the study will assess intervention adherence, patient satisfaction, and safety (as measured by the incidence of adverse events) through systematic review and network meta-analysis.</p><p><strong>Methods: </strong>A systematic search will be conducted in the following databases: PubMed/MEDLINE, EMBASE, Cochrane Library, Scopus, and Web of Science, covering all records from database inception to 31 December 2025. Eligible studies will include randomized controlled trials (RCTs) involving adults (≥ 18 years) with CLBP, comparing telerehabilitation interventions to any control intervention. The primary outcome will be pain intensity, while secondary outcomes will include physical function, psychological status, quality of life, and adverse events. The risk of bias for the included studies will be assessed using the revised Cochrane Risk of Bias 2.0 tool. The certainty of evidence will be evaluated using the CINeMA (Confidence in Network Meta-Analysis) web application. All network meta-analyses will be conducted within a frequentist framework using Stata 15 software and will apply random-effects models. Intervention rankings will be estimated using Surface Under the Cumulative Ranking (SUCRA) curves and illustrated with forest plots showing both individual and pooled effect sizes. Additional analyses will include assessments of statistical inconsistency, publication bias, heterogeneity, sensitivity, and subgroup differences.</p><p><strong>Discussion: </strong>This study aimed to compare and rank the available evidence on various forms of telerehabilitation for the management of CLBP, as well as to assess its safety. The findings offer valuable insights for healthcare professionals and policymakers, supporting the advancement of patient-centered rehabilitation strategies.</p><p><strong>Systematic review registration: </strong>PROSPERO CRD420251015478.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147327175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-28DOI: 10.1186/s13643-026-03132-x
Ghada Aleinati, Maryam Alsamhan, Reema AlJassar, Sadan Alhajeri, Alaa AlAli
Background: Traditionally, monocular interventions, like patching, have been the gold standard in amblyopia treatment. However, the current understanding that amblyopia is a binocular rather than monocular condition has inspired a surge in binocular treatments, which encourage the simultaneous use of both eyes.
Objectives: This systematic review aims to evaluate the effects of binocular treatment for amblyopia among children (9 years and younger) versus standard monocular interventions (patching or atropine eye drops) in terms of best corrected visual acuity (BCVA), treatment adherence, and patient/caregiver-reported outcomes. Secondary outcomes include change in other visual outcomes (stereoacuity and contrast sensitivity), reported barriers to treatment, reported side effects, and sustained improvement in BCVA on follow up.
Methods: A comprehensive search will be conducted on three databases (PubMed, Embase, and CENTRAL) and two trial registries (ClinicalTrials.gov and WHO ICTRP). A previous search will be updated to include results since inception through March 2026. Two blinded, independent reviewers will screen titles and abstracts against predetermined criteria. Eligible studies will undergo full-text screening by two blinded, independent reviewers. Randomized controlled trials that compare binocular and monocular interventions for amblyopia among children younger than 9 years of age will be included. The quality of included studies will be evaluated using the Cochrane risk of bias tool for randomized trials (RoB-2). Data analysis will be carried out using Revman software. Continuous variables will be summarized using mean difference (MD) and 95% confidence intervals [CI]. Meta-analyses will be performed employing random-effects models.
Discussion: Although similar reviews exist, binocular therapy is a fairly novel and nuanced treatment. As such, new research continues to add to the growing body of evidence. Furthermore, existing reviews mainly focus on post-interventional visual outcomes, while this review will also shine light on outcomes like adherence, patient or caregiver reported outcomes, reported barriers and side effects, and sustained improvement after treatment cessation. These outcomes will be important to all stakeholders involved: patients, caregivers, healthcare providers, and policy makers, especially with such a pervasive condition that can affect multiple aspects of a child's life, in addition to their family's lives, with possible consequences carried into adulthood.
{"title":"Binocular versus standard therapy for amblyopia - effect on visual acuity, adherence, and patient or caregiver reported outcomes: protocol for a systematic review.","authors":"Ghada Aleinati, Maryam Alsamhan, Reema AlJassar, Sadan Alhajeri, Alaa AlAli","doi":"10.1186/s13643-026-03132-x","DOIUrl":"https://doi.org/10.1186/s13643-026-03132-x","url":null,"abstract":"<p><strong>Background: </strong>Traditionally, monocular interventions, like patching, have been the gold standard in amblyopia treatment. However, the current understanding that amblyopia is a binocular rather than monocular condition has inspired a surge in binocular treatments, which encourage the simultaneous use of both eyes.</p><p><strong>Objectives: </strong>This systematic review aims to evaluate the effects of binocular treatment for amblyopia among children (9 years and younger) versus standard monocular interventions (patching or atropine eye drops) in terms of best corrected visual acuity (BCVA), treatment adherence, and patient/caregiver-reported outcomes. Secondary outcomes include change in other visual outcomes (stereoacuity and contrast sensitivity), reported barriers to treatment, reported side effects, and sustained improvement in BCVA on follow up.</p><p><strong>Methods: </strong>A comprehensive search will be conducted on three databases (PubMed, Embase, and CENTRAL) and two trial registries (ClinicalTrials.gov and WHO ICTRP). A previous search will be updated to include results since inception through March 2026. Two blinded, independent reviewers will screen titles and abstracts against predetermined criteria. Eligible studies will undergo full-text screening by two blinded, independent reviewers. Randomized controlled trials that compare binocular and monocular interventions for amblyopia among children younger than 9 years of age will be included. The quality of included studies will be evaluated using the Cochrane risk of bias tool for randomized trials (RoB-2). Data analysis will be carried out using Revman software. Continuous variables will be summarized using mean difference (MD) and 95% confidence intervals [CI]. Meta-analyses will be performed employing random-effects models.</p><p><strong>Discussion: </strong>Although similar reviews exist, binocular therapy is a fairly novel and nuanced treatment. As such, new research continues to add to the growing body of evidence. Furthermore, existing reviews mainly focus on post-interventional visual outcomes, while this review will also shine light on outcomes like adherence, patient or caregiver reported outcomes, reported barriers and side effects, and sustained improvement after treatment cessation. These outcomes will be important to all stakeholders involved: patients, caregivers, healthcare providers, and policy makers, especially with such a pervasive condition that can affect multiple aspects of a child's life, in addition to their family's lives, with possible consequences carried into adulthood.</p><p><strong>Systematic review registration: </strong>PROSPERO CRD42024502274.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147322006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Children and adolescents with autism spectrum disorder (ASD) frequently experience sleep problems. Although various pharmacological, behavioral, and physical interventions have demonstrated efficacy in improving sleep among children with ASD, the relative effectiveness of these interventions remains unclear.
Methods: We will conduct a systematic literature search to identify randomized controlled trials that evaluate the efficacy of pharmacological (e.g., melatonin), psychological (e.g., cognitive behavioral therapy), and physical (e.g., bright light therapy) interventions for sleep problems in children with ASD. We will search PubMed, PsycINFO, Cochrane CENTRAL, major trial registries, and regulatory agency websites. We will assess the Cochrane Risk of Bias 2.0 (RoB 2.0) tool for primary outcome and the Risk Of Bias due to Missing Evidence in Network meta-analysis (ROB-MEN) tool for the bias due to missing network evidence. A network meta-analysis (NMA) will be performed to compare the included interventions. The primary outcome will be sleep onset latency, while secondary outcomes will include other sleep variables, all-cause dropouts, and sleep disturbances assessed using standardized measures. We will assess confidence in NMA(CINeMA).
Discussion: Our NMA aims to provide evidence-based insights into the effectiveness of sleep interventions for clinicians, children with ASD, and their caregivers. This information will help guide treatment decisions and improve the quality of life for children with ASD and their families.
{"title":"Comparative efficacy and acceptability of sleep interventions for children and adolescents with autism spectrum disorders: a protocol for a systematic review and network meta-analysis.","authors":"Masatsugu Sakata, Edoardo G Ostinelli, Ryuichiro Yamamoto, Hitomi Oi, Shino Kikuchi, Rie Toyomoto, Shun Nakajima, Kei Ohashi, Akane Nogimura, Rie Yamada, Laurie McLay, Toshi A Furukawa, Yukiyo Nagai, Atsurou Yamada","doi":"10.1186/s13643-026-03143-8","DOIUrl":"https://doi.org/10.1186/s13643-026-03143-8","url":null,"abstract":"<p><strong>Background: </strong>Children and adolescents with autism spectrum disorder (ASD) frequently experience sleep problems. Although various pharmacological, behavioral, and physical interventions have demonstrated efficacy in improving sleep among children with ASD, the relative effectiveness of these interventions remains unclear.</p><p><strong>Methods: </strong>We will conduct a systematic literature search to identify randomized controlled trials that evaluate the efficacy of pharmacological (e.g., melatonin), psychological (e.g., cognitive behavioral therapy), and physical (e.g., bright light therapy) interventions for sleep problems in children with ASD. We will search PubMed, PsycINFO, Cochrane CENTRAL, major trial registries, and regulatory agency websites. We will assess the Cochrane Risk of Bias 2.0 (RoB 2.0) tool for primary outcome and the Risk Of Bias due to Missing Evidence in Network meta-analysis (ROB-MEN) tool for the bias due to missing network evidence. A network meta-analysis (NMA) will be performed to compare the included interventions. The primary outcome will be sleep onset latency, while secondary outcomes will include other sleep variables, all-cause dropouts, and sleep disturbances assessed using standardized measures. We will assess confidence in NMA(CINeMA).</p><p><strong>Discussion: </strong>Our NMA aims to provide evidence-based insights into the effectiveness of sleep interventions for clinicians, children with ASD, and their caregivers. This information will help guide treatment decisions and improve the quality of life for children with ASD and their families.</p><p><strong>Systematic review registration: </strong>PROSPERO CRD42024592795.</p>","PeriodicalId":22162,"journal":{"name":"Systematic Reviews","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147318267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}